What are the indications and management for thrombolysis in ST-Elevation Myocardial Infarction (STEMI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Thrombolysis Indications and Management in STEMI

Thrombolytic therapy is indicated in all STEMI patients with symptoms of ischemia less than 12 hours duration and persistent ST-segment elevation when primary PCI cannot be performed in a timely manner (within 120 minutes of first medical contact). 1

Primary Indications for Thrombolysis in STEMI

  • First-line indication: When primary PCI cannot be performed within 120 minutes after STEMI diagnosis 1
  • Time window: Within 12 hours of symptom onset in patients without contraindications 1
  • ECG criteria: Persistent ST-segment elevation or new-onset left bundle branch block 1
  • Administration timing: Should be initiated as soon as possible after STEMI diagnosis, preferably in the pre-hospital setting 1

Contraindications to Thrombolysis

Thrombolytic therapy is contraindicated in patients with:

  • Active internal bleeding
  • History of cerebrovascular accident
  • Intracranial or intraspinal surgery or trauma within 2 months
  • Intracranial neoplasm, arteriovenous malformation, or aneurysm
  • Known bleeding diathesis
  • Severe uncontrolled hypertension 2

Thrombolytic Agent Selection and Administration

  • Preferred agents: Fibrin-specific agents (tenecteplase, alteplase, or reteplase) 1
  • Tenecteplase dosing: Individualized based on patient's weight, administered as a single bolus over 5 seconds 2
  • Administration route: Intravenous only 2

Adjunctive Antithrombotic Therapy with Thrombolysis

  1. Antiplatelet therapy:

    • Oral or IV aspirin (162-325 mg) 1, 3
    • Clopidogrel in addition to aspirin 1
  2. Anticoagulation:

    • Required until revascularization or for duration of hospital stay (up to 8 days) 1
    • Preferred option: Enoxaparin IV followed by subcutaneous (superior to UFH) 1
    • Alternative: Unfractionated heparin as weight-adjusted IV bolus followed by infusion 1
    • Contraindicated: Fondaparinux is not recommended 1

Post-Thrombolysis Management

  1. Transfer strategy:

    • All patients should be transferred to a PCI-capable center immediately after fibrinolysis 1
    • Angiography and PCI of the infarct-related artery (if indicated) is recommended between 2-24 hours after successful fibrinolysis 1
  2. Rescue PCI indications:

    • Failed thrombolysis (<50% ST-segment resolution at 60-90 minutes) 1
    • Hemodynamic or electrical instability 1
    • Worsening ischemia 1
    • Heart failure or cardiogenic shock 1
    • Recurrent ischemia or evidence of reocclusion after initially successful thrombolysis 1

Special Considerations for Timing

  • Early presenters (within 2 hours of symptom onset) may have particular benefit from thrombolysis compared to delayed primary PCI 4
  • For patients <75 years with large anterior infarction presenting within 2 hours of symptom onset, primary PCI should be performed within 90 minutes of first medical contact 3
  • If primary PCI cannot be performed within the recommended timeframe, thrombolysis should be initiated within 30 minutes of first medical contact 5

Post-Reperfusion Care

  • Echocardiography during hospital stay to assess LV and RV function, detect mechanical complications, and exclude LV thrombus 1
  • Cardiac rehabilitation program participation is recommended 1
  • Smoking cessation support with nicotine replacement therapies, varenicline, and bupropion 1

Monitoring for Complications

  • Bleeding: Avoid intramuscular injections and nonessential handling of the patient for the first few hours following treatment 2
  • Arrhythmias: Have anti-arrhythmic therapy available for bradycardia and/or ventricular irritability 2
  • Hypersensitivity: Monitor patients during and for several hours after infusion 2
  • Cholesterol embolism: Has been reported with thrombolytic agents 2

Key Pitfalls to Avoid

  1. Delayed administration: Thrombolytic efficacy decreases with time; administer as soon as possible after STEMI diagnosis
  2. Inappropriate patient selection: Carefully screen for contraindications to minimize bleeding risk
  3. Failure to transfer: All patients should be transferred to a PCI-capable center after thrombolysis
  4. Missing failed thrombolysis: Monitor for signs of reperfusion failure and perform rescue PCI when indicated
  5. Inadequate anticoagulation: Ensure proper anticoagulation is maintained after thrombolysis

The evidence strongly supports a reperfusion strategy that prioritizes timely treatment. While primary PCI is the preferred method when available within the recommended timeframe, thrombolysis remains a critical intervention when timely PCI is not feasible, with subsequent transfer to a PCI-capable facility for potential early intervention.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.